Mycapssa
Payments companies reported to CMS as associated with Mycapssa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mycapssa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mycapssa
These are the largest totals companies reported as associated with Mycapssa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wenyu Huang | Chicago, IL | Endocrinology, Diabetes & Metabolism | $91,348.67 |
| Anthony Heaney | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $80,245.53 |
| Elena Christofides | Columbus, OH | Endocrinology, Diabetes & Metabolism | $50,751.75 |
| Intekhab Ahmed | Philadelphia, PA | Endocrinology, Diabetes & Metabolism | $34,578.44 |
| Philip Rabito | New York, NY | $29,505.77 | |
| Malini Gupta | Memphis, TN | Endocrinology, Diabetes & Metabolism | $27,629.28 |
| Kevin Yuen | Phoenix, AZ | Endocrinology, Diabetes & Metabolism | $24,575.83 |
| Isaac Sachmechi | New Hyde Park, NY | Endocrinology, Diabetes & Metabolism | $22,677.69 |
| Nidhi Agrawal | New York, NY | Endocrinology, Diabetes & Metabolism | $21,434.41 |
| Lisa Myers | Germantown, TN | Endocrinology, Diabetes & Metabolism | $18,884.23 |
Prescribed Mycapssa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.